Sedeek Abdelrahman M, Elfeky Hossam, Hanora Amro S, Solyman Samar M
Department of Microbiology and Immunology, Faculty of Pharmacy, Galala University, New Galala City, Suez, 43511, Egypt.
Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.
BMC Microbiol. 2025 Jun 26;25(1):372. doi: 10.1186/s12866-025-04109-x.
Marine actinobacteria represent a diverse and biotechnologically rich group of microorganisms that have adapted to the unique challenges of marine ecosystems, including fluctuating salinities, temperatures, pressures, and nutrient levels. These environmental pressures have enhanced their biosynthetic capabilities, making them a prolific source of novel bioactive compounds.
In this research, we report the isolation of a novel marine bacterium "Streptomyces albidoflavus VIP-1" associated with the marine invertebrate Molgula citrine isolated from the Red Sea. The secondary metabolites from the isolated strain exhibited significant in vitro antimicrobial and antitumor activities. The isolate has an estimated genome length of 7,090,100 base pairs. Based on the phylogenomic analysis and the values of digital DNA-DNA hybridization, average amino acids identity, and average nucleotide identity in comparison to genomes of known type strains, the isolated strain was found to belong to the species of Streptomyces albidoflavus. The genome of S. albidoflavus VIP-1 revealed genetic adaptations enabling its survival in harsh environments, including stress response genes and regulatory systems. Moreover, a wide variety of biosynthetic gene clusters belonging to polyketides, terpenes, and non-ribosomal peptides were detected. Finally, a comparative genome analysis with related marine and terrestrial strains highlighted its elevated biosynthetic potential.
The genome of S. albidoflavus VIP-1 reflects its potential as a valuable resource for biotechnological and biomedical applications. It reveals genetic adaptation to the marine environment through various anti-stress mechanisms and competitive strategies, including the production of antimicrobial metabolites.
海洋放线菌是一类多样且具有丰富生物技术价值的微生物,它们已经适应了海洋生态系统的独特挑战,包括盐度、温度、压力和营养水平的波动。这些环境压力增强了它们的生物合成能力,使其成为新型生物活性化合物的丰富来源。
在本研究中,我们报告了从红海分离的与海洋无脊椎动物柠檬海鞘相关的新型海洋细菌“白色链霉菌VIP-1”的分离。从分离菌株中获得的次生代谢产物表现出显著的体外抗菌和抗肿瘤活性。该分离株的估计基因组长度为7,090,100个碱基对。基于系统基因组分析以及与已知模式菌株基因组相比的数字DNA-DNA杂交值、平均氨基酸同一性和平均核苷酸同一性,发现该分离株属于白色链霉菌种。白色链霉菌VIP-1的基因组揭示了使其能够在恶劣环境中生存的遗传适应性,包括应激反应基因和调控系统。此外,还检测到了属于聚酮化合物、萜类和非核糖体肽的多种生物合成基因簇。最后,与相关海洋和陆地菌株的比较基因组分析突出了其提高的生物合成潜力。
白色链霉菌VIP-1的基因组反映了其作为生物技术和生物医学应用宝贵资源的潜力。它通过各种抗应激机制和竞争策略,包括抗菌代谢产物的产生,揭示了对海洋环境的遗传适应性。